Genxone SA

WAR:GX1 (Poland)   Ordinary Shares
zł 6.40 (0%) May 14
At Loss
P/B:
1.41
Market Cap:
zł 21.10M ($ 5.35M)
Enterprise V:
zł 12.16M ($ 3.08M)
Volume:
4.17K
Avg Vol (2M):
2.99K

Business Description

Description
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.97
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 25.64
Distress
Grey
Safe
Beneish M-Score 4.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -51.1
3-Year Book Growth Rate 0.2
Name Current Vs Industry Vs History
5-Day RSI 18.24
9-Day RSI 32.55
14-Day RSI 39.41
6-1 Month Momentum % -8.96
12-1 Month Momentum % -36.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.94
Quick Ratio 16.59
Cash Ratio 13.15
Days Inventory 46.49
Days Sales Outstanding 72.33
Days Payable 32.6

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials

WAR:GX1's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genxone SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł) 2.395
EPS (TTM) (zł) -1.128
Beta 0.07
Volatility % 61.67
14-Day RSI 39.41
14-Day ATR (zł) 0.41836
20-Day SMA (zł) 6.898
12-1 Month Momentum % -36.46
52-Week Range (zł) 5 - 10.3
Shares Outstanding (Mil) 3.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genxone SA Filings

Filing Date Document Date Form
No Filing Data

Genxone SA Stock Events

Financials Calendars
Event Date Price(zł)
No Event Data

Genxone SA Frequently Asked Questions

What is Genxone SA(WAR:GX1)'s stock price today?
The current price of WAR:GX1 is zł6.40. The 52 week high of WAR:GX1 is zł10.30 and 52 week low is zł5.00.
When is next earnings date of Genxone SA(WAR:GX1)?
The next earnings date of Genxone SA(WAR:GX1) is .
Does Genxone SA(WAR:GX1) pay dividends? If so, how much?
Genxone SA(WAR:GX1) does not pay dividend.

Press Release

Subject Date
No Press Release